Banking & Finance

Fangda has substantial multi-jurisdictional expertise in cross-border banking and financing transactions, representing many major international and domestic financial institutions and borrowers/sponsors in a wide range of complex banking and finance matters.

Our financing lawyers are admitted to practice law in Mainland China, Hong Kong SAR, and England and Wales. We are well-known for our strength in cross-border banking and finance transactions.

Acquisition Financing

We have a leading practice in acquisition finance involving acquisition in China and by Chinese acquirers. We regularly represent the largest and most sophisticated financial sponsors and corporate borrowers, or financing banks, and have been retained by them in financing some of the largest China-related transactions in the last decade.

Project Financing

With the support from the firm’s project, real estate and corporate teams, we have structured and led major project financing transactions in many countries. We have been involved in various project financings involving developments in the petrochemical, power and energy, infrastructure, water, real estate, transportation and waste disposal industries.

Structured Finance

We have specialist expertise in structured financing products such as margin securities financing and highly structured mezzanine debt and other structured financial products.

Recognition

  • Banking and Finance - Tier 1
    IFLR 1000 Financial Law Firm Rankings, 2015-2021
  • Banking and Finance - Outstanding
    Asialaw Profiles, 2018-2021
  • Finance Law Firm of the Year
    Chambers Asia-Pacific China Awards, 2020
  • Banking and Finance: PRC firms - Tier 1
    The Legal 500 Asia Pacific, 2019-2021
  • Banking & Finance (PRC Firms) - Band 2
    Chambers Asia-Pacific, 2015-2021

"Well regarded for its broad range of services ranging from syndicated loans to cross-border term loan facilities. Particularly noted for its expertise in domestic and international acquisition financing and non-recourse project financing."

Chambers Asia-Pacific

Notable Matters

We have represented clients on many important banking and finance deals. A snapshot of some of our banking and financing clients and deals includes representing:

Banking & Finance

Leveraged and Acquisition Finance
  • The consortium comprising Boyu Capital, Ally Bridge, Temasek, Yunfeng Capital, Sequoia and Hillhouse in a syndicate loan facility granted by Ping An Bank and Shanghai Pudong Development Bank for privatization of WuXi PharmaTech (Cayman) Inc., which was listed on the New York Stock Exchange.
  • The founders of Mindray Medical International in a term loan facility granted by Bank of China and Ping An Bank for privatization of Mindray Medical International.
  • The consortium led by Zhou Hongyi in a syndicated loan facility arranged by China Merchants Bank Co., Shenzhen Branch for privatization of Qihoo 360 Technology, which is listed on the New York Stock Exchange.
  • Onshore syndicate lenders consisting of China Merchant Bank, Shanghai Pudong Development Bank, Ping An Bank, Bank of China, China Minsheng Bank and Industrial Bank in an acquisition financing to a consortium comprising Hillhouse and other investors for the purpose of acquiring 15% shares of GREE Electric Appliances.
  • China Development Bank Hong Kong Branch, China Minsheng Banking Corp Hong Kong Branch, Bank of America, Citibank, Credit Suisse Singapore Branch, DBS, Deutsche Bank Hong Kong Branch and ICBC International on a term loan to a consortium comprising Carlyle Asia Partners, FountainVest, CITIC Capital and China Everbright Structured Investment Holdings for the privatization of Focus Media Holdings, which was listed on NASDAQ.
  • Ping An Bank in a RMB facility granted to China Neptunus Drugstore Holding for the privatization of China Nepstar Chain Drugstore.
  • Onshore and offshore syndicate lenders comprising DBS, China Minsheng Bank, China Merchant Bank and Maybank on an acquisition financing to a consortium comprising Vanke, SCPG and Hopu to acquire 20 onshore shopping mall projects from Capitaland.
  • Ping An Bank on a term loan to Anta Group for its acquisition of Amer Sports.
Project Finance
  • The mandated lead arrangers, including ICBC, China Construction Bank, Bank of China, Agricultural Bank of China, China Development Bank and Bank of Communications, on a loan facility to Fujian Refining and Petrochemical Co. for the development of an oil refining and ethylene facility in Fujian Province.
  • Mori Building on a loan facility for the construction and development of Shanghai World Finance Center in Shanghai.
  • The Export-Import Bank of China in a U.S. dollar term loan facility to the Republic of Djibouti for the development of Doraleh port.
  • Shanghai Krupp Stainless Co. on a syndicate loan facility for the development of its stainless steel plant.
  • Shanghai Chemical Industry Park Industry Gas, on a U.S. dollar syndicate loan facility for project development.
  • Bayer Polymers (Shanghai) Company on a bilateral loan from China Construction Bank for project development.
  • Syndicate lenders led by Bank of Communications on a RMB loan facility for development of Shanghai Port International Passenger Transport Center.
  • Syndicate lenders led by Bank of China Shanghai Jing’An Sub-Branch on a RMB facility for the construction and development of HKRI Taikoo Hui in Jing’An district, Shanghai.
  • Shanghai Yaoda Real Estate Development on a RMB syndicate loan for development of Shanghai Intercontinental Center.
Structured Finance and Corporate Lending
  • HSBC, Bank of China Hong Kong Branch and JPMorgan Chase in parallel loans to Shanghai International Port (Group) Co. for investment in H-share issuance of Postal Savings Bank of China.
  • ICBC International in a U.S. dollar facility to Huarong Group for investment purposes.
  • Charoen Pokphand Group on a number of loan facilities with various Hong Kong-based financial institutions.
  • China Construction Bank Shenzhen Branch in a funded risk participation transaction for granting a U.S. dollar term loan facility to Hepalink USA Inc.